Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Summary sheet

Release date
2 October 2020
Status
Reference
Approved | 11/11/2020
20200584
Project name
Promoter - financial intermediary
COVID-19 ESSENTIAL API MANUFACTURING IN AFRICA
COUNTERPART(S) TO BE DETERMINED
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 50 million
EUR 100 million
Location
Sector(s)
  • Health - Human health and social work activities
Description
Objectives

The operation aims at increasing the local manufacturing capacity of active pharmaceutical ingredients (APIs) in sub-Saharan Africa (SSA).

The operation aims at increasing the local manufacturing capacity of active pharmaceutical ingredients (APIs) in sub-Saharan Africa. The ultimate objective is to improve the availability of pharmaceutical products in the region and to increase the robustness of the pharmaceutical supply chain by reducing dependency on imports.

Environmental aspects
Procurement

The overall environmental impact and the residual environmental risks of the operation are unknown at this stage and will be assessed at the appraisal of individual sub-operations. The Bank will require the beneficiaries to ensure that implementation of the sub-projects will be done in accordance with the Bank's environmental and social policy and standards.

The Bank will require that the beneficiaries ensure that the implementation of the sub-operations will be done in accordance with the Bank's Guide to Procurement.

Related projects
Related sub-project
Related sub-project

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - COVID-19 ESSENTIAL API MANUFACTURING IN AFRICA
Publication Date
26 Nov 2020
Document language
Main Topic
Lending
Document Number
133740236
Document Focus
Environmental Information
Project Number
20200584
Sector(s)
Countries
Publicly available
Download now
Environmental and Social Data Sheet (ESDS) - RWANDA VACCINE MANUFACTURING
Publication Date
31 Jan 2024
Document language
Main Topic
Lending
Document Number
163212926
Document Focus
Environmental Information
Project Number
20200584
Sector(s)
Countries
Publicly available
Download now
Other links

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

Related publications